BCL
BCL inhibitors are compounds that target the BCL-2 family of proteins, which play a key role in the regulation of apoptosis. The BCL-2 family includes both pro-apoptotic and anti-apoptotic members that control the mitochondrial pathway of apoptosis. Inhibiting anti-apoptotic BCL-2 proteins can promote cell death in cancer cells, making BCL inhibitors crucial in cancer therapy research. At CymitQuimica, we provide a comprehensive selection of high-quality BCL inhibitors to support your research in cancer, apoptosis, and cell biology.
Found 3 products of "BCL"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
BM 957
CAS:BM 957 is an effective Bcl-2 and Bcl-xL inhibitor (Kis: 1.2 and <1 nM; IC50s: 5.4 and 6.0 nM).Formula:C52H56ClF3N6O7S3Purity:98%Color and Shape:SolidMolecular weight:1065.68Tapotoclax
CAS:Tapotoclax (AMG-176) is an orally active MCL1 inhibitor for the study of myeloid leukemia.Formula:C33H41ClN2O5SPurity:98.8%Color and Shape:SolidMolecular weight:613.21Mcl1-IN-9
CAS:Mcl1-IN-9 is a potent myeloid cell leukemia-1 (Mcl-1) Inhibitor with an IC50 of 446 nM in reengineered BCR-ABL+ B-ALL cells and a Ki of 0.03 nM.
Formula:C37H39ClN4O4Purity:98%Color and Shape:SolidMolecular weight:639.18
